The estimated Net Worth of Kirk G. Nielsen is at least $2.8 Milione dollars as of 27 May 2023. Kirk Nielsen owns over 2,982 units of Inari Medical stock worth over $2,770,859 and over the last 4 years Kirk sold NARI stock worth over $24,720.
Kirk has made over 4 trades of the Inari Medical stock since 2021, according to the Form 4 filled with the SEC. Most recently Kirk exercised 2,982 units of NARI stock worth $134,399 on 27 May 2023.
The largest trade Kirk's ever made was exercising 2,983 units of Inari Medical stock on 26 May 2022 worth over $134,444. On average, Kirk trades about 915 units every 81 days since 2020. As of 27 May 2023 Kirk still owns at least 61,479 units of Inari Medical stock.
You can see the complete history of Kirk Nielsen stock trades at the bottom of the page.
Kirk's mailing address filed with the SEC is C/O INARI MEDICAL, INC., 6001 OAK CANYON, IRVINE, CA, 92618.
Over the last 4 years, insiders at Inari Medical have traded over $519,947,508 worth of Inari Medical stock and bought 1,100,480 units worth $22,863,324 . The most active insiders traders include Gilde Healthcare Iv U.A.Gil..., William Hoffman e Andrew Hykes. On average, Inari Medical executives and independent directors trade stock every 7 days with the average trade being worth of $1,998,809. The most recent stock trade was executed by Andrew Hykes on 20 August 2024, trading 3,000 units of NARI stock currently worth $150,000.
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Inari Medical executives and other stock owners filed with the SEC include: